The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Development of a risk calculator of recurrence in inguinal lymph node metastatic (ILNM) patients with surgically resected penile squamous cell carcinoma (PSCC).
 
Marco Bandini
No Relationships to Disclose
 
Yao Zhu
No Relationships to Disclose
 
Dingwei Ye
No Relationships to Disclose
 
Antonio Augusto Ornellas
No Relationships to Disclose
 
Nick Watkin
No Relationships to Disclose
 
Michael Ager
No Relationships to Disclose
 
Oliver W. Hakenberg
No Relationships to Disclose
 
Axel Heidenreich
Honoraria - Amgen; Astellas Pharma; Bayer; Ferring; Ipsen; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; Bayer; Clovis Oncology; Janssen-Cilag
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Ipsen; Johnson & Johnson; Pfizer; Sanofi; Takeda
Research Funding - Astellas Pharma; Bayer; Sanofi
 
Daniele Raggi
No Relationships to Disclose
 
Mario Catanzaro
No Relationships to Disclose
 
Laura Marandino
No Relationships to Disclose
 
Friederike Haidl
No Relationships to Disclose
 
Francesco Montorsi
No Relationships to Disclose
 
Juan Chipollini
No Relationships to Disclose
 
Mounsif Azizi
No Relationships to Disclose
 
Maarten Albersen
No Relationships to Disclose
 
Roberto Salvioni
No Relationships to Disclose
 
Oscar Brouwer
No Relationships to Disclose
 
Philippe E. Spiess
Honoraria - UptoDate
Other Relationship - NCCN
 
Andrea Necchi
Employment - Bayer (I)
Stock and Other Ownership Interests - Bayer (I)
Honoraria - AstraZeneca; Foundation Medicine; Janssen; Merck; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Incyte; Janssen; Merck Sharp & Dohme; Rainier Therapeutics; Roche; Seattle Genetics/Astellas
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Merck Sharp & Dohme; Rainier Therapeutics; Roche
Other Relationship - Bayer (I)